Human medicines European public assessment report (EPAR): Ezmekly, mirdametinib, Date of authorisation: 17/07/2025, Revision: 2, Status: Authorised

Other fees and charges for medicinal products for human use, veterinary medicinal products and consultations on medical devices

Human medicines European public assessment report (EPAR): Xbonzy, denosumab, Date of authorisation: 17/11/2025, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Evrenzo, roxadustat, Date of authorisation: 18/08/2021, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Olazax Disperzi, olanzapine, Date of authorisation: 10/12/2009, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Zoledronic acid Actavis, zoledronic acid, Date of authorisation: 20/04/2012, Revision: 16, Status: Withdrawn

EMA actively monitoring cruise ship Hantavirus outbreak

Human medicines European public assessment report (EPAR): Zoledronic Acid Hospira, zoledronic acid, Date of authorisation: 19/11/2012, Revision: 19, Status: Withdrawn

EMA business hours over Ascension Day holidays, 14 and 15 May

Article 57 product data